Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Dedicated

- PMLiVE

Prof Sir Mike Richards joins Incisive Health as senior counsel

He recently stepped down as chief inspector of hospitals

AI’s potential in the pharma life cycle

At a time that the future of life sciences is being hotly debated, the opportunity for the industry to refine and expand its role is an important one to take...

- PMLiVE

Dr Paula Salmikangas joins NDA Group

Moves to the regulatory affairs consultancy from the Finnish Medicines Agency

- PMLiVE

And breathe…

…or, why there is no ‘fast track’  to communications excellence

- PMLiVE

Humanisation

The key to delivering communications excellence

- PMLiVE

Merck, Pfizer cue up first EU launches for PD-L1 drug Bavencio

Germany and the UK will be the first to receive the skin cancer treatment

- PMLiVE

Intercept hit hard as FDA issues Ocaliva safety notice

The PBC treatment has been linked to 19 deaths and 11 cases of liver damage

- PMLiVE

Translation company Conversis appoints Jamie Newall as CEO

He will also sit on the UK firm's board

- PMLiVE

Former GSK CEO joins Synthego’s advisory board

Sir Andrew Witty will expand the team’s bioinformatics expertise

- PMLiVE

Attracting doctors to low-demand specialties

A role for industry?

- PMLiVE

Signal strength

Communications that connect

- PMLiVE

Novartis gets EU nod for leukaemia drug Rydapt

The FLT3 inhibitor adds to its US approval in AML

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links